Dr Eva Baxter joined QCGC Research in January 2018. Eva completed her PhD in Oncology at the University of Edinburgh in 2012. Eva is a Research Fellow and Team Leader of our biomarker and molecular research program. This involves investigating markers (such as in blood or a tumour biopsy) that will identify if a woman with endometrial cancer can safely avoid having a hysterectomy and instead be treated conservatively.